Clean Cells
Mission and values
Since our creation, we have always aimed at providing the biopharmaceutical industry with innovative solutions in order to take part in the development of new therapies. Individuals are at the heart of our considerations and our projects; our customers, our providers, our partners and our own team are all given a particular attention. Trust and benevolence are Clean Cells’ core values and we endeavor to apply them in all circumstances. After 18 years working for the enhanced safety of biologics and building our team’s expertise, Clean Cells is now using the momentum to establish itself as a CDMO for innovative therapies.
Our goal remains the same: do our part in patients’ well-being.
Olivier Boisteau, President and CEO at Clean Cells
In the news
See all news
Covid-19 information
Clean Cells maintains its usual level of activity
In the context of the coronavirus (CoviD-19) epidemic, Clean Cells' teams are closely monitoring the evolution of the situation in order to guarantee business continuity but also to protect the safety and health of our employees.
BE Vaccines is now NAOBIOS
After joining Clean Cells on March 1st, 2019, BE Vaccines has been renamed NAOBIOS.
Created originally by the Valneva Group (ex-Vivalis) in 2005, then taken over by the Indian company Biological E in 2013 with the aim of stepping up the technical development of viral vaccines, BE VACCINES joined CLEAN CELLS on March 1st, 2019.
Clean Biologics was born in 2018 from a fruitful alliance between Clean Cells and Archimed. Through this partnership, the group soon acquired and integrated CDMO Naobios to extend the service offer and to promote our future-oriented thinking. The expertise, transparency, progress and a human-centred view are at the core of our identity. Day after day, we use our knowledge and our skills to deliver high-quality services in innovative projects with an unwavering dynamism and commitment.
140
customers around the world
Over 6000
analysis per year